Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Maria Elisabeth Lendorf"'
Autor:
Maria Elisabeth Lendorf, Peter Meidahl Petersen, Andrea Steen Svendsen, Henriette Lindberg, Klaus Brasso
Publikováno v:
European Urology Open Science, Vol 24, Iss , Pp 25-33 (2021)
Background: Addition of docetaxel to androgen deprivation therapy (ADT) for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) has been proved to be effective with an overall survival (OS) benefit in phase III clinical trials. The
Externí odkaz:
https://doaj.org/article/a618105dd97a4437a63f2b1c4bc003b7
Autor:
Mikkel Porsborg Andersen, Christian Torp-Pedersen, Helle Collatz Christensen, Ulrik Pedersen-Bjergaard, Thomas Alexander Gerds, Amalie Lykkemark Moeller, Birgitte Lindegaard, Mille Dybdal Cajar, Florence Chia Chin Tan, Mogens Karsboel Boisen, Sebastian Moretto Krog, Rúna Nolsoee, Peter Lommer Kristensen, Thomas Broe Christensen, Maria Elisabeth Lendorf
Publikováno v:
BMJ Open, Vol 12, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/4e480064c20242769291b01a042f3373
Autor:
Henriette Lindberg, Klaus Brasso, Andrea Steen Svendsen, Peter Meidahl Petersen, Maria Elisabeth Lendorf
Publikováno v:
European Urology Open Science, Vol 24, Iss, Pp 25-33 (2021)
Lendorf, M E, Petersen, P M, Svendsen, A S, Lindberg, H & Brasso, K 2021, ' Effectiveness of Docetaxel for Metastatic Hormone-sensitive Prostate Cancer in Clinical Practice ', European Urology Open Science, vol. 24, pp. 25-33 . https://doi.org/10.1016/j.euros.2020.12.006
European Urology Open Science
Lendorf, M E, Petersen, P M, Svendsen, A S, Lindberg, H & Brasso, K 2021, ' Effectiveness of Docetaxel for Metastatic Hormone-sensitive Prostate Cancer in Clinical Practice ', European Urology Open Science, vol. 24, pp. 25-33 . https://doi.org/10.1016/j.euros.2020.12.006
European Urology Open Science
Background Addition of docetaxel to androgen deprivation therapy (ADT) for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) has been proved to be effective with an overall survival (OS) benefit in phase III clinical trials. The e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89060e3ce9adbcc50990365fd0eec48c
https://doi.org/10.1016/j.euros.2020.12.006
https://doi.org/10.1016/j.euros.2020.12.006
Autor:
Mille Dybdal Cajar, Florence Chia Chin Tan, Mogens Karsboel Boisen, Sebastian Moretto Krog, Rúna Nolsoee, Helle Collatz Christensen, Mikkel Porsborg Andersen, Amalie Lykkemark Moeller, Thomas Alexander Gerds, Ulrik Pedersen-Bjergaard, Birgitte Lindegaard, Peter Lommer Kristensen, Thomas Broe Christensen, Christian Torp-Pedersen, Maria Elisabeth Lendorf
Publikováno v:
BMJ Open. 12:e056393
ObjectiveTo study the association between behavioural factors and incidence rates of SARS-CoV-2 infection.DesignCase–control web-based questionnaire study.SettingQuestionnaire data were collected in the Capital Region of Denmark in December 2020 wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3071046f66a4f67f049b90ca667ca6f2
https://doi.org/10.1136/bmjopen-2021-056393
https://doi.org/10.1136/bmjopen-2021-056393
Autor:
Helle Pappot, Anand C Loya, Bára Oladóttir á Dunga, Line Hammer Dohn, Maria Elisabeth Lendorf
Publikováno v:
Scandinavian Journal of Urology. 52:87-93
The aim of the present study was to emphasize the critical importance of the clinician's awareness of signet-ring cell carcinoma (SRCC) of the urinary bladder, a rare and aggressive disease entity.A review of the current literature was conducted and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65f456c6102b7741897365141d031686
https://doi.org/10.1080/21681805.2017.1418020
https://doi.org/10.1080/21681805.2017.1418020
Autor:
Pauliina Kronqvist, John R. Couchman, Tina Manon-Jensen, Maria Elisabeth Lendorf, Hinke A.B. Multhaupt
Publikováno v:
Journal of Histochemistry & Cytochemistry. 59:615-629
Syndecan proteoglycans may be key regulators of tumor invasion and metastasis because this four-member family of transmembrane receptors regulates cell adhesion, proliferation, and differentiation. Their expression can also serve as prognostic marker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b2b4517516647715cf948f4984f62cb
https://doi.org/10.1369/0022155411405057
https://doi.org/10.1369/0022155411405057
Publikováno v:
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 60(1)
Tumor markers are widely used in pathology not only for diagnostic purposes but also to assess the prognosis and to predict the treatment of the tumor. Because tumor marker levels may change over time, it is important to get a better understanding of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2edf4fc03b423e5d3283c065097eceb9
https://pubmed.ncbi.nlm.nih.gov/22205677
https://pubmed.ncbi.nlm.nih.gov/22205677
Autor:
Louise Brinth, Stig Molsted, Maria Elisabeth Lendorf, Maria Hein Hegelund, Camilla Kock Ryrsø, Dorthe Holm Sommer, Lilian Kolte, Nolsöe, Rúna L., Thomas Ingemann Pedersen, Zitta Barella Harboe, Andrea Browatzki, Lisbeth Brandi, Sebastian Moretto Krog, Morten Bestle, Inger Merete Jørgensen, Tomas Østergaard Jensen, Tk, Fischer, Ulrik Pedersen-Bjergaard, Birgitte Lindegaard
Publikováno v:
Capital Region of Denmark
Schouborg, L B, Molsted, S, Lendorf, M E, Hegelund, M H, Ryrsø, C K, Sommer, D H, Kolte, L, Nolsöe, R L, Pedersen, T I, Harboe, Z B, Browatzki, A, Brandi, L, Krog, S M, Bestle, M H, Jørgensen, I M, Jensen, T Ø, Fischer, T K, Pedersen-Bjergaard, U & Lindegaard, B 2022, ' Risk factors for fatigue and impaired function eight months after hospital admission with COVID-19 ', Danish Medical Journal, vol. 69, no. 4, A08210633 . < https://ugeskriftet.dk/dmj/risk-factors-fatigue-and-impaired-function-eight-months-after-hospital-admission-covid-19 >
Schouborg, L B, Molsted, S, Lendorf, M E, Hegelund, M H, Ryrsø, C K, Sommer, D H, Kolte, L, Nolsöe, R L, Pedersen, T I, Harboe, Z B, Browatzki, A, Brandi, L, Krog, S M, Bestle, M H, Jørgensen, I M, Jensen, T Ø, Fischer, T K, Pedersen-Bjergaard, U & Lindegaard, B 2022, ' Risk factors for fatigue and impaired function eight months after hospital admission with COVID-19 ', Danish Medical Journal, vol. 69, no. 4, A08210633 . < https://ugeskriftet.dk/dmj/risk-factors-fatigue-and-impaired-function-eight-months-after-hospital-admission-covid-19 >
INTRODUCTION: We aimed to evaluate post-COVID-19 fatigue, change in functional capacity and health-related quality of life (HRQoL) eight months after discharge from hospital due to COVID-19.METHODS: A total of 83 patients (35 women) admitted to the C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e46e1c87bc62f5ff1d37e729767d3a18
https://research.regionh.dk/en/publications/risk-factors-for-fatigue-and-impaired-function-eight-months-after-hospital-admission-with-covid19(90ba19b4-6269-4805-97af-2e993b686cea).html
https://research.regionh.dk/en/publications/risk-factors-for-fatigue-and-impaired-function-eight-months-after-hospital-admission-with-covid19(90ba19b4-6269-4805-97af-2e993b686cea).html
Autor:
Maria Elisabeth Lendorf, Mogens Karsbøl Boisen, Peter Lommer Kristensen, Ellen Christine Leth Løkkegaard, Sebastian Moretto Krog, Lisbet Brandi, Louise Brinth, Rúna Louise Mortansdóttir Nolsöe, Camilla Ryrsø, Pia Eiken, Morten Bestle, Inger Merete Jørgensen, Ulrik Pedersen-Bjergaard, Birgitte Lindegaard, Thomas Broe Christensen, Thea Kølsen Fischer
Publikováno v:
University of Copenhagen
Capital Region of Denmark
Lendorf, M E, Boisen, M K, Kristensen, P L, Løkkegaard, E C L, Krog, S M, Brandi, L, Brinth, L S, Nolsöe, R L M, Ryrsø, C, Eiken, P, Bestle, M H, Jørgensen, I M, Pedersen-Bjergaard, U, Lindegaard, B, Christensen, T B & Fischer, T K 2020, ' Characteristics and early outcomes of patients hospitalised for covid-19 in North Zealand, Denmark ', Danish Medical Journal, vol. 67, no. 9, A06200428, pp. 1-11 . < https://ugeskriftet.dk/dmj/characteristics-and-early-outcomes-patients-hospitalised-covid-19-north-zealand-denmark >
Capital Region of Denmark
Lendorf, M E, Boisen, M K, Kristensen, P L, Løkkegaard, E C L, Krog, S M, Brandi, L, Brinth, L S, Nolsöe, R L M, Ryrsø, C, Eiken, P, Bestle, M H, Jørgensen, I M, Pedersen-Bjergaard, U, Lindegaard, B, Christensen, T B & Fischer, T K 2020, ' Characteristics and early outcomes of patients hospitalised for covid-19 in North Zealand, Denmark ', Danish Medical Journal, vol. 67, no. 9, A06200428, pp. 1-11 . < https://ugeskriftet.dk/dmj/characteristics-and-early-outcomes-patients-hospitalised-covid-19-north-zealand-denmark >
INTRODUCTION: Coronavirus disease 2019 (COVID-19) is an ongoing pandemic associated with significant morbidity and mortality worldwide. Limited data are available describing the clinical presentation and outcomes of hospitalised COVID-19 patients in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::df6efad2cb574fb2ee1532997bb0803f
https://curis.ku.dk/portal/en/publications/characteristics-and-early-outcomes-of-patients-hospitalised-for-covid19-in-north-zealand-denmark(12ca6ba4-6008-40b0-a3cf-89764e72962d).html
https://curis.ku.dk/portal/en/publications/characteristics-and-early-outcomes-of-patients-hospitalised-for-covid19-in-north-zealand-denmark(12ca6ba4-6008-40b0-a3cf-89764e72962d).html
Autor:
Caroline Klint Johannesen, Gry St Martin, Maria Elisabeth Lendorf, Peter Garred, Alexander Fyfe, Paton, Robert S., Craig Thompson, Stig Molsted, Caroline Elisabeth Kann, Claus Antonio Jensen, Cecilie Bo Hansen, Ellen Løkkegaard, Thomas Broe Christensen, Peter Simons, Thea Kølsen Fischer
Publikováno v:
Capital Region of Denmark
Knowledge of the seroprevalence and duration of antibodies against SARS-CoV-2 was needed in the early phases of the COVID-19 pandemic and is still necessary for policy makers and healthcare professionals. This information allows us to better understa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::69d70d98eb18ab1c9810dbe22be75ff0
https://research.regionh.dk/en/publications/prevalence-and-duration-of-antisarscov2-antibodies-in-healthcare-workers(ef0b5dd5-aefb-44f6-8ea0-555b4c0607ad).html
https://research.regionh.dk/en/publications/prevalence-and-duration-of-antisarscov2-antibodies-in-healthcare-workers(ef0b5dd5-aefb-44f6-8ea0-555b4c0607ad).html